Literature DB >> 29439351

Relationship of Area of Soft Drusen in Retina with Cerebral Amyloid-β Accumulation and Blood Amyloid-β Level in the Elderly.

Chiho Shoda1, Yorihisa Kitagawa1, Hiroyuki Shimada1, Mitsuko Yuzawa1, Amane Tateno2, Yoshiro Okubo2.   

Abstract

BACKGROUND: Histopathological studies have confirmed that soft drusen contains amyloid-β (Aβ).
OBJECTIVE: To examine the relationship between the area of soft drusen in the macular area and cerebral Aβ accumulation or plasma Aβ level in elderly persons without dementia.
METHODS: Fourteen consecutive patients (18 eyes) aged ≥50 years with macular soft drusen were studied prospectively. From color fundus photographs, the area of soft drusen (pixel) within a 6,000 μm diameter with the macula as center was measured. Standard uptake value ratio (SUVR) was obtained from positron emission tomography using florbetapir, which indicates the ratio of cerebral cortical-to-cerebellar Aβ accumulation. Ratio of plasma Aβ1-42 to Aβ1-40 level was calculated.
RESULTS: Mean age was 73.3±7.6 years. The soft drusen area was 4.32±2.42 mm2. The SUVR was 1.08±0.15. Plasma Aβ1-42/Aβ1-40 ratio was 0.17±0.08. When SUVR ≥1.10 was defined as positive and <1.10 as negative, the soft drusen area in SUVR-positive patients (6.19±1.14 mm2) was significantly (p = 0.0043) larger than that in SUVR-negative patients (3.13±2.27 mm2). Multivariate regression analysis showed that SUVR positivity correlated with soft drusen area (p = 0.0484) and with Voxel-based Specific Regional Analysis System for Alzheimer's Disease score (p = 0.0360). However, there was no correlation with gender (p = 0.1921), age (p = 0.2361), Alzheimer's Disease Assessment Scale score (p = 0.6310), Mini-Mental State Examination score (p = 0.4246), or plasma Aβ1-42/Aβ1-40 ratio (p = 0.8398).
CONCLUSION: Among elderly persons without dementia, the area of soft drusen was larger in those with more extensive cerebral Aβ accumulation. The area of soft drusen may be a biomarker of cerebral Aβ accumulation.

Entities:  

Keywords:  Alzheimer’s disease; amyloid; dementia; florbetapir; macular degeneration; positron-emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29439351     DOI: 10.3233/JAD-170956

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

Review 1.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 2.  Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications.

Authors:  Liang Wang; Xiaobo Mao
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

3.  CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.

Authors:  Biju Bhargavan; Shawna M Woollard; Jo Ellyn McMillan; Georgette D Kanmogne
Journal:  Mol Neurodegener       Date:  2021-11-22       Impact factor: 14.195

4.  Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.

Authors:  Shannon L Risacher; Noelia Fandos; Judith Romero; Ian Sherriff; Pedro Pesini; Andrew J Saykin; Liana G Apostolova
Journal:  Alzheimers Dement (Amst)       Date:  2019-07-26

5.  The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.

Authors:  Qingqin S Li; Chao Tian; David Hinds; Guy R Seabrook
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.